Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
Saved in:
| Title: | Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL. |
|---|---|
| Authors: | Bouroumeau A; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Bussot L; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France., Sartelet H; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., Fournier C; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, Dijon, France., Betton-Fraisse P; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Col E; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., David-Boudet L; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France., McLeer A; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France., Lefebvre C; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Raskovalova T; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Jacob MC; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Vettier C; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Chevalier S; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Algrin C; Daniel Hollard Institute, Grenoble, France., Carras S; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France.; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Gressin R; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France., Callanan MB; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, Dijon, France., Bonnefoix T; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, Grenoble, France., Emadali A; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, Grenoble, France. |
| Source: | HemaSphere [Hemasphere] 2021 Jun 12; Vol. 5 (7), pp. e598. Date of Electronic Publication: 2021 Jun 12 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
